Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Worldwide Prevalence of Familial Hypercholesterolemia
Sabina Beheshti, Christian M. Madsen, Anette Varbo, et al.
Journal of the American College of Cardiology (2020) Vol. 75, Iss. 20, pp. 2553-2566
Open Access | Times Cited: 436

Showing 1-25 of 436 citing articles:

Heart Disease and Stroke Statistics—2021 Update
Salim S. Virani, Álvaro Alonso, Hugo J. Aparicio, et al.
Circulation (2021) Vol. 143, Iss. 8
Open Access | Times Cited: 4684
Heart Disease and Stroke Statistics—2022 Update: A Report From the American Heart Association
Connie W. Tsao, Aaron W. Aday, Zaid Almarzooq, et al.
Circulation (2022) Vol. 145, Iss. 8
Open Access | Times Cited: 4211
Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association
Connie W. Tsao, Aaron W. Aday, Zaid Almarzooq, et al.
Circulation (2023) Vol. 147, Iss. 8
Open Access | Times Cited: 4138
2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association
Seth S. Martin, Aaron W. Aday, Zaid Almarzooq, et al.
Circulation (2024) Vol. 149, Iss. 8
Open Access | Times Cited: 837
Evinacumab in Patients with Refractory Hypercholesterolemia
Robert S. Rosenson, Lesley Burgess, Christoph Ebenbichler, et al.
New England Journal of Medicine (2020) Vol. 383, Iss. 24, pp. 2307-2319
Open Access | Times Cited: 244
Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)
Antonio J. Vallejo‐Vaz, C. Stevens, Alexander R.M. Lyons, et al.
The Lancet (2021) Vol. 398, Iss. 10312, pp. 1713-1725
Closed Access | Times Cited: 220
2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance
Marina Cuchel, Frederick J. Raal, Robert A. Hegele, et al.
European Heart Journal (2023) Vol. 44, Iss. 25, pp. 2277-2291
Open Access | Times Cited: 150
Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2022
Tomonori Okamura, Kazuhisa Tsukamoto, Hidenori Arai, et al.
Journal of Atherosclerosis and Thrombosis (2023) Vol. 31, Iss. 6, pp. 641-853
Open Access | Times Cited: 134
PoLA/CFPiP/PCS/PSLD/PSD/PSH guidelines on diagnosis and therapy of lipid disorders in Poland 2021
Maciej Banach, Paweł Burchardt, Krzysztof Chlebus, et al.
Archives of Medical Science (2021) Vol. 17, Iss. 6, pp. 1447-1547
Open Access | Times Cited: 132
International Atherosclerosis Society guidance for implementing best practice in the care of familial hypercholesterolaemia
Gerald F. Watts, Samuel S. Gidding, Robert A. Hegele, et al.
Nature Reviews Cardiology (2023) Vol. 20, Iss. 12, pp. 845-869
Open Access | Times Cited: 126
Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study
Tycho R. Tromp, Merel L. Hartgers, G. Kees Hovingh, et al.
The Lancet (2022) Vol. 399, Iss. 10326, pp. 719-728
Open Access | Times Cited: 125
APOE gene variants in primary dyslipidemia
Yara Abou Khalil, Jean‐Pierre Rabès, Cathérine Boileau, et al.
Atherosclerosis (2021) Vol. 328, pp. 11-22
Open Access | Times Cited: 105
The Lancet Commission to reduce the global burden of sudden cardiac death: a call for multidisciplinary action
Éloi Marijon, Kumar Narayanan, Karen Smith, et al.
The Lancet (2023) Vol. 402, Iss. 10405, pp. 883-936
Closed Access | Times Cited: 88
Ten things to know about ten cardiovascular disease risk factors – 2022
Harold Bays, Anandita Agarwala, Charles German, et al.
American Journal of Preventive Cardiology (2022) Vol. 10, pp. 100342-100342
Open Access | Times Cited: 79
Guidelines for the Diagnosis and Treatment of Adult Familial Hypercholesterolemia 2022
Mariko Harada‐Shiba, Hidenori Arai, Hirotoshi Ohmura, et al.
Journal of Atherosclerosis and Thrombosis (2023) Vol. 30, Iss. 5, pp. 558-586
Open Access | Times Cited: 48
Lipid metabolism during pregnancy: consequences for mother and child
Janneke W.C.M. Mulder, D. Meeike Kusters, Jeanine E. Roeters van Lennep, et al.
Current Opinion in Lipidology (2024) Vol. 35, Iss. 3, pp. 133-140
Open Access | Times Cited: 24
Overweight, obesity, and cardiovascular disease in heterozygous familial hypercholesterolaemia: the EAS FH Studies Collaboration registry
Amany Elshorbagy, Antonio J. Vallejo‐Vaz, Fotios Barkas, et al.
European Heart Journal (2025)
Open Access | Times Cited: 3
Ages at coronary heart disease and death in familial hypercholesterolaemia: a Danish nationwide study spanning 44 years
Jacob Reeh, Shoaib Afzal, Anders Berg Wulff, et al.
European Heart Journal (2025)
Closed Access | Times Cited: 2
Homozygous Familial Hypercholesterolemia
Atsushi Nohara, Hayato Tada, Masatsune Ogura, et al.
Journal of Atherosclerosis and Thrombosis (2021)
Open Access | Times Cited: 84
Integrated Guidance for Enhancing the Care of Familial Hypercholesterolaemia in Australia
Gerald F. Watts, David Sullivan, David L. Hare, et al.
Heart Lung and Circulation (2020) Vol. 30, Iss. 3, pp. 324-349
Open Access | Times Cited: 79
Genetic and molecular architecture of familial hypercholesterolemia
Marianne Abifadel, Cathérine Boileau
Journal of Internal Medicine (2022) Vol. 293, Iss. 2, pp. 144-165
Open Access | Times Cited: 60
Paediatric familial hypercholesterolaemia screening in Europe: public policy background and recommendations
Samuel S. Gidding, Albert Wiegman, Urh Grošelj, et al.
European Journal of Preventive Cardiology (2022) Vol. 29, Iss. 18, pp. 2301-2311
Open Access | Times Cited: 59
Familial Hypercholesterolemia-Risk-Score: A New Score Predicting Cardiovascular Events and Cardiovascular Mortality in Familial Hypercholesterolemia
Martine Paquette, Sophie Bernard, Bertrand Cariou, et al.
Arteriosclerosis Thrombosis and Vascular Biology (2021) Vol. 41, Iss. 10, pp. 2632-2640
Open Access | Times Cited: 58
Recent Advances on Familial Hypercholesterolemia in Children and Adolescents
Francesca Mainieri, Veronica Maria Tagi, Francesco Chiarelli
Biomedicines (2022) Vol. 10, Iss. 5, pp. 1043-1043
Open Access | Times Cited: 41
Guidelines for the Diagnosis and Treatment of Pediatric Familial Hypercholesterolemia 2022
Mariko Harada‐Shiba, Akira Ohtake, Daisuke Sugiyama, et al.
Journal of Atherosclerosis and Thrombosis (2023) Vol. 30, Iss. 5, pp. 531-557
Open Access | Times Cited: 35
Page 1 - Next Page

Scroll to top